Case of the Month

Challenging Skin Toxicity in a Patient Receiving Amivantamab

Challenging Skin Toxicity in a Patient Receiving Amivantamab

Read more
Challenging Skin Toxicity in a Patient Receiving Amivantamab

When Standard Therapy Fails: Immune-Related Colitis

Read more

A Challenging Case of Immune-Related SJS/TEN Overlap

Read more

When Immunotherapy Impacts the Brain: ICANS Following ICI Therapy

Read more

When Immunotherapy Affects Multiple Organs: Nivolumab-Induced Multi-Toxicity

Read more

65-year-old male patient with Pembrolizumab-induced Lichen planus

Read more

71-year-old male patient with Ipilimumab/Nivolumab-induced Triple M syndrome (Myasthenia gravis, Myositis, Myocarditis)

Read more

60-year-old male patient with Nivolumab-induced polyarthritis and suspected necrotizing fasciitis

Read more

Participate and document cases of rare, complex, severe and therapy-refractory side effects induced by immunotherapy

Join our team of experts for analysis of irAE

Initiate or contribute to research projects with regard to irAE

Access our Database